The test for interactions did not reach statistical significance for sex, types of antidiabetic medications or BMI (all p for interaction >0.05), indicating that the stronger association of RC with MASLD than LDL-C did not differ by sex, types of antidiabetic medications or BMI status.
← all excerpts
Discordant high remnant cholesterol with LDL-C increases the metabolic dysfunction-associated steatotic liver disease risk in patients with type 2 diabetes mellitus.
1
—
—